Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
In patients with CRPA infections susceptible to traditional NCBL, there was no statisticallly significant difference in 30-day mortality among patients who were treated with traditional NCBL compared with NVL. Further studies with larger sample sizes are needed to confirm these findings.
Authors
- M. ALHARBI (ORCID: https://orcid.org/0009-0007-7998-0222)
- Raghad T. Alhuthil
- Thamer A. Almangour (ORCID: https://orcid.org/0000-0003-1508-8693)
- Abdulrahman A. Almalki
- Mohammed I. Al Musawa
- Raed Alharbi (ORCID: https://orcid.org/0000-0003-0247-3824)
- Namareq Fahad Aldardeer (ORCID: https://orcid.org/0000-0001-9323-1606)
- Hatun M. Labban
- Seham H. Aljahdali
Institutions
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Wayne State University (US)
- King Faisal Specialist Hospital & Research Centre (SA)
- King Saud Medical City (SA)
- King Saud University (SA)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1186/s12879-024-10365-5
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Faisal Specialist Hospital and Research Centre
- King Saud University